EcoDrugPlus

Amine Oxidase Copper Containing 3

Ensembl ID : ENSG00000131471
Gene: AOC3
Gene Synonyms: HPAO,VAP-1,VAP1
1 APIs:
3 Enzyme and pathways 7 Cross references
317 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Amylase Alpha 2a

Ensembl ID : ENSG00000243480
Gene: AMY2A
Gene Synonyms: AMY2
1 APIs:
3 Enzyme and pathways 7 Cross references
192 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Amyloid P Component, Serum

Ensembl ID : ENSG00000132703
Gene: APCS
Gene Synonyms: MGC88159,PTX2,SAP
2 APIs:
2 Enzyme and pathways 7 Cross references
402 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Amyloid Beta Precursor Protein

Ensembl ID : ENSG00000142192
Gene: APP
Gene Synonyms: AD1,ALPHA-SAPP
11 APIs:
64 Enzyme and pathways 8 Cross references
279 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Androgen Receptor

Ensembl ID : ENSG00000169083
Gene: AR
Gene Synonyms: AIS,DHTR,HUMARA,NR3C4,SBMA,SMAX1
40 APIs:
23 Enzyme and pathways 9 Cross references
277 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Angiotensin I Converting Enzyme

Ensembl ID : ENSG00000159640
Gene: ACE
Gene Synonyms: ACE1,CD143,DCP1
18 APIs:
3 Enzyme and pathways 8 Cross references
92 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSG00000144891
Gene: AGTR1
Gene Synonyms: AG2S,AGTR1A,AGTR1B,AT1,AT1B,AT2R1,AT2R1A,AT2R1B,ATR1,HAT1R
16 APIs:
11 Enzyme and pathways 8 Cross references
214 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSG00000180772
Gene: AGTR2
Gene Synonyms: AT2,MRX88
1 APIs:
7 Enzyme and pathways 7 Cross references
195 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSG00000117362
Gene: APH1A
Gene Synonyms: APH-1A,CGI-78
5 APIs:
33 Enzyme and pathways 7 Cross references
138 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSG00000138613
Gene: APH1B
Gene Synonyms: APH-1B,DKFZP564D0372,PSFL
5 APIs:
33 Enzyme and pathways 7 Cross references
193 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSG00000100823
Gene: APEX1
Gene Synonyms: APE,APE-1,APEN,APEX,APX,HAP1,REF-1,REF1
1 APIs:
9 Enzyme and pathways 7 Cross references
214 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSG00000108839
Gene: ALOX12
Gene Synonyms: 12S-LOX
1 APIs:
13 Enzyme and pathways 7 Cross references
198 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).